Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities

Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis

(2016) Eliana Botta et al.   ATHEROSCLEROSIS

Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis

(2016) E. Ikdahl et al.   JOURNAL OF RHEUMATOLOGY

Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?

(2016) Ximing Liao et al.   European Journal of Preventive Cardiology

Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors

(2015) Aikaterini Arida et al.   CLINICAL RHEUMATOLOGY

The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls

(2015) A. Sodergren et al.   JOURNAL OF RHEUMATOLOGY

Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies

(2015) A. Arida et al.   JOURNAL OF RHEUMATOLOGY

Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

(2015) Sarah Skeoch et al.   Nature Reviews Rheumatology

Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?

(2015) Lodewijk de Groot et al.   RHEUMATOLOGY

Insulin Resistance in Rheumatoid Arthritis: Disease-Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis

(2015) Jon T. Giles et al.   Arthritis & Rheumatology

Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis

(2015) Robert Winchester et al.   Arthritis & Rheumatology

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab

(2015) Sella Aarrestad Provan et al.   PLoS One

Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis

(2014) C. H. Im et al.   RHEUMATOLOGY

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

(2014) E. Choy et al.   RHEUMATOLOGY

Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?

(2014) L.-S. Tam et al.   RHEUMATOLOGY

Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis

(2013) G. Bamias et al.   CLINICAL IMMUNOLOGY

Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case-control study

(2012) Athanase Protogerou et al.   ANNALS OF THE RHEUMATIC DISEASES

Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study

(2012) Evangelia Zampeli et al.   ARTHRITIS RESEARCH & THERAPY

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Atherosclerosis in Rheumatoid Arthritis Versus Diabetes

(2009) Kimon S. Stamatelopoulos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY